Abstract:This work describes an efficient, simple, and green bioprocess for obtaining 5‐halogenated pyrimidine nucleosides from thymidine by transglycosylation using whole cells. Biosynthesis of 5‐fluoro‐2′‐deoxyuridine (floxuridine) was achieved by free and immobilized Aeromonas salmonicida ATCC 27013 with an 80% and 65% conversion occurring in 1 h, respectively. The immobilized biocatalyst was stable for more than 4 months in storage conditions (4 °C) and could be reused at least 30 times without loss of its activity… Show more
“…Besides the optimization of the enzymatic synthesis process by thermodynamic calculation, the present study also investigated the impact of a chlorine atom at position 6 of the nucleoside with respect to its inhibitory effect on leukemic cells. This was based on the observation that halogenation is an important prerequisite for anticancer activity [3,23,24], since amino groups make the compound susceptible to deamination by adenosine deaminase (ADA) [25,26]. The addition of a chlorine or fluorine atom in position 2 of adenosine strongly increased its stability, as observed for the very potent leukemia drugs cladribine and fludarabine [23,26].…”
Section: Discussionmentioning
confidence: 99%
“…Due to the drawbacks of chemical synthesis routes, alternative methods have been developed. Enzymatic synthesis is environmentally more friendly, highly selective, and efficient [3]. The most commonly applied enzyme-catalyzed reaction for the preparation of nucleosides and their analogues is the one-pot transglycosylation with pyrimidine and purine nucleoside phosphorylases [4].…”
The enzymatic synthesis of nucleoside analogues has been shown to be a sustainable and efficient alternative to chemical synthesis routes. In this study, dihalogenated nucleoside analogues were produced by thermostable nucleoside phosphorylases in transglycosylation reactions using uridine or thymidine as sugar donors. Prior to the enzymatic process, ideal maximum product yields were calculated after the determination of equilibrium constants through monitoring the equilibrium conversion in analytical-scale reactions. Equilibrium constants for dihalogenated nucleosides were comparable to known purine nucleosides, ranging between 0.071 and 0.081. To achieve 90% product yield in the enzymatic process, an approximately five-fold excess of sugar donor was needed. Nucleoside analogues were purified by semi-preparative HPLC, and yields of purified product were approximately 50% for all target compounds. To evaluate the impact of halogen atoms in positions 2 and 6 on the antiproliferative activity in leukemic cell lines, the cytotoxic potential of dihalogenated nucleoside analogues was studied in the leukemic cell line HL-60. Interestingly, the inhibition of HL-60 cells with dihalogenated nucleoside analogues was substantially lower than with monohalogenated cladribine, which is known to show high antiproliferative activity. Taken together, we demonstrate that thermodynamic calculations and small-scale experiments can be used to produce nucleoside analogues with high yields and purity on larger scales. The procedure can be used for the generation of new libraries of nucleoside analogues for screening experiments or to replace the chemical synthesis routes of marketed nucleoside drugs by enzymatic processes.
“…Besides the optimization of the enzymatic synthesis process by thermodynamic calculation, the present study also investigated the impact of a chlorine atom at position 6 of the nucleoside with respect to its inhibitory effect on leukemic cells. This was based on the observation that halogenation is an important prerequisite for anticancer activity [3,23,24], since amino groups make the compound susceptible to deamination by adenosine deaminase (ADA) [25,26]. The addition of a chlorine or fluorine atom in position 2 of adenosine strongly increased its stability, as observed for the very potent leukemia drugs cladribine and fludarabine [23,26].…”
Section: Discussionmentioning
confidence: 99%
“…Due to the drawbacks of chemical synthesis routes, alternative methods have been developed. Enzymatic synthesis is environmentally more friendly, highly selective, and efficient [3]. The most commonly applied enzyme-catalyzed reaction for the preparation of nucleosides and their analogues is the one-pot transglycosylation with pyrimidine and purine nucleoside phosphorylases [4].…”
The enzymatic synthesis of nucleoside analogues has been shown to be a sustainable and efficient alternative to chemical synthesis routes. In this study, dihalogenated nucleoside analogues were produced by thermostable nucleoside phosphorylases in transglycosylation reactions using uridine or thymidine as sugar donors. Prior to the enzymatic process, ideal maximum product yields were calculated after the determination of equilibrium constants through monitoring the equilibrium conversion in analytical-scale reactions. Equilibrium constants for dihalogenated nucleosides were comparable to known purine nucleosides, ranging between 0.071 and 0.081. To achieve 90% product yield in the enzymatic process, an approximately five-fold excess of sugar donor was needed. Nucleoside analogues were purified by semi-preparative HPLC, and yields of purified product were approximately 50% for all target compounds. To evaluate the impact of halogen atoms in positions 2 and 6 on the antiproliferative activity in leukemic cell lines, the cytotoxic potential of dihalogenated nucleoside analogues was studied in the leukemic cell line HL-60. Interestingly, the inhibition of HL-60 cells with dihalogenated nucleoside analogues was substantially lower than with monohalogenated cladribine, which is known to show high antiproliferative activity. Taken together, we demonstrate that thermodynamic calculations and small-scale experiments can be used to produce nucleoside analogues with high yields and purity on larger scales. The procedure can be used for the generation of new libraries of nucleoside analogues for screening experiments or to replace the chemical synthesis routes of marketed nucleoside drugs by enzymatic processes.
“…Biocatalyst stabilization 2.5.1. Matrix selection E. coli ATCC 12407 was immobilized by entrapment in agar gracilaria 3% (w/v), agar gelidium 3% (w/v), agarose 3% (w/v) and polyacrylamide 20% (w/v) as described by Rivero et al [14].…”
“…This modified nucleoside is mainly synthesized by chemical methods, however, its biocatalytic synthesis using microorganisms is a promising alternative 3. Nevertheless, the application of microorganisms in soluble form is limited by their low stability 4. Currently, different immobilization techniques have allowed to stabilize biocatalysts, facilitating their reusability, favoring their biocatalytic activity and bioprocess scale‐up 5.…”
Bionanocomposites employing natural polysaccharides such as alginate and nanoclays, e.g., bentonite, are a promising alternative to developing stabilized biocatalysts used in the pharmaceutical industry due to their physicochemical properties, biocompatibility, and nontoxicity. Mechanical parameters such as swelling ratio, compressive strength, and fracture frequency were optimized, favoring scale-up. Moreover, storage stability and reusability of the biocatalysts were improved by more than 90 % compared with control conditions. In addition, immobilized lactic acid bacteria were used in the bioprocess scale-up to obtain floxuridine, showing a high productivity per gram of biocatalyst.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.